These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 27769906)
21. Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers. Nagano N; Muranaka A; Nishikawa R; Ohwada W; Kouzu H; Kamiyama N; Fujito T; Mochizuki A; Nagahara D; Nakanishi M; Ohkubo Y; Hisahara S; Nakao S; Katoh N; Ishikawa A; Sakurai A; Yano T Int Heart J; 2022; 63(1):168-175. PubMed ID: 35095067 [TBL] [Abstract][Full Text] [Related]
22. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995 [TBL] [Abstract][Full Text] [Related]
23. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308 [TBL] [Abstract][Full Text] [Related]
24. [Problems of diagnostics and treatment of transtiretinum amyloidosis with destruction of the heart in the elderly: Clinical experience.]. Boldueva SA; Petrova VB; Khavinson VK; Samohvalova MV; Petrova AI Adv Gerontol; 2019; 32(1-2):137-144. PubMed ID: 31228380 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556 [TBL] [Abstract][Full Text] [Related]
26. Therapy of ATTR Cardiac Amyloidosis: Current Indications. Di Lisi D; Di Stefano V; Brighina F; Galassi AR; Novo G Curr Probl Cardiol; 2023 Feb; 48(2):101487. PubMed ID: 36336119 [TBL] [Abstract][Full Text] [Related]
27. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types. Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632 [TBL] [Abstract][Full Text] [Related]
29. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy. Hänselmann A; Berliner D; Bauersachs J; Bavendiek U Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775 [TBL] [Abstract][Full Text] [Related]
30. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study. Béquignon E; Guellich A; Bartier S; Raynal M; Prulière-Escabasse V; Canouï-Poitrine F; Coste A; Damy T Amyloid; 2017 Jun; 24(2):96-100. PubMed ID: 28598686 [TBL] [Abstract][Full Text] [Related]
40. Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies. Warner AL Pharmacotherapy; 2021 Dec; 41(12):1081-1091. PubMed ID: 34669976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]